dipyridamole has been researched along with Liver Cirrhosis in 6 studies
Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.
Liver Cirrhosis: Liver disease in which the normal microcirculation, the gross vascular anatomy, and the hepatic architecture have been variably destroyed and altered with fibrous septa surrounding regenerated or regenerating parenchymal nodules.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Thromboxane B2 production was slightly increased." | 5.27 | Failure of two anti-platelet drugs (indobufen and dipyridamole) to improve thrombocytopenia in liver cirrhosis. ( Fabris, F; Gerunda, GE; Girolami, A; Luzzatto, G; Zangrandi, F, 1987) |
| "We have determined the extrarenal sorbitol clearance (14 cases) and the Congestion Index (seven cases) before and at 30, 60, and 90 min after the oral administration of 25 mg dipyridamole in patients with liver cirrhosis." | 5.08 | Beneficial hemodynamic effects of dipyridamole on portal circulation in cirrhosis. ( D'Alimonte, P; Ferrari, A; Manenti, F; Romagnoli, R; Sansoè, G; Trenti, T; Villa, E; Zoboli, P, 1998) |
| "Thromboxane B2 production was slightly increased." | 1.27 | Failure of two anti-platelet drugs (indobufen and dipyridamole) to improve thrombocytopenia in liver cirrhosis. ( Fabris, F; Gerunda, GE; Girolami, A; Luzzatto, G; Zangrandi, F, 1987) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (50.00) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Umgelter, A | 1 |
| Llach, J | 1 |
| Ginès, P | 1 |
| Arroyo, V | 1 |
| Salmerón, JM | 1 |
| Ginès, A | 1 |
| Jiménez, W | 1 |
| Gaya, J | 1 |
| Rivera, F | 1 |
| Rodés, J | 1 |
| Sansoè, G | 1 |
| Ferrari, A | 1 |
| D'Alimonte, P | 1 |
| Trenti, T | 1 |
| Zoboli, P | 1 |
| Romagnoli, R | 1 |
| Villa, E | 1 |
| Manenti, F | 1 |
| McKenzie, PE | 1 |
| Taylor, AE | 1 |
| Woodroffe, AJ | 1 |
| Seymour, AE | 1 |
| Chan, YL | 1 |
| Clarkson, AR | 1 |
| Luzzatto, G | 2 |
| Fabris, F | 2 |
| Gerunda, GE | 2 |
| Zangrandi, F | 1 |
| Girolami, A | 2 |
| De Franchis, G | 1 |
1 review available for dipyridamole and Liver Cirrhosis
| Article | Year |
|---|---|
[Approach to the patient with zirrhotic ascites--no diagnosis without a tap].
Topics: Aminoglycosides; Angiotensin-Converting Enzyme Inhibitors; Anti-Inflammatory Agents, Non-Steroidal; | 2010 |
1 trial available for dipyridamole and Liver Cirrhosis
| Article | Year |
|---|---|
Beneficial hemodynamic effects of dipyridamole on portal circulation in cirrhosis.
Topics: Administration, Oral; Adult; Aged; Dipyridamole; Female; Hemodynamics; Humans; Liver Circulation; Li | 1998 |
4 other studies available for dipyridamole and Liver Cirrhosis
| Article | Year |
|---|---|
Effect of dipyridamole on kidney function in cirrhosis.
Topics: Ascites; Dipyridamole; Diuresis; Hormones; Humans; Kidney; Liver Cirrhosis; Natriuresis; Renin-Angio | 1993 |
Plasmapheresis in glomerulonephritis.
Topics: Adolescent; Adult; Agammaglobulinemia; Anti-Glomerular Basement Membrane Disease; Complement System | 1979 |
Failure of two anti-platelet drugs (indobufen and dipyridamole) to improve thrombocytopenia in liver cirrhosis.
Topics: Aged; beta-Thromboglobulin; Blood Platelets; Dipyridamole; Female; Humans; Isoindoles; Liver Cirrhos | 1987 |
Full dose dipyridamole significantly improves thrombocytopenia in liver cirrhosis.
Topics: Adult; Aged; Dipyridamole; Female; Humans; Liver Cirrhosis; Male; Middle Aged; Platelet Count; Throm | 1987 |